HealthQuill Adverse Cardiovascular Events
Cytokinetics, a US-based biopharmaceutical company, announced the FDA had rejected its new drug application for approving a trial drug to treat heart problems with reduced ejection fraction (HFrEF).
Health Medical Research

Muscle fat raises heart disease risk, independent of BMI, study finds

HQ Team January 20, 2024:People with fat stored within their muscles, known as intermuscular fat, face a significantly higher risk of serious cardiovascular.

Read More
The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering from heart problems or stroke.
Drugs Health Pharma

Novo Nordisk’s Wegovy gets UK regulator nod to treat heart risks

The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering.

Read More